Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall by Steve Jones April 28, 2025April 28, 2025 Manufacturer Bioxyne said it expects to resume revenue growth in the final quarter of the financial […]
Bioxyne upgrades revenue forecast on back of record Q2 by Martin Lane January 24, 2025January 29, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’ by Steve Jones September 26, 2024September 26, 2024
BLS delivers first gummies manufactured under GMP licence by Martin Lane August 21, 2024January 13, 2025
Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira by Steve Jones July 31, 2024November 25, 2024
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma by Martin Lane and Steve Jones April 16, 2024July 16, 2024
